VC  Open Prairie Ventures

     Office Locations:

400 East Jefferson
Effingham, IL 62410
Phone: 217-347-1000
Fax: 217-347-1001

Get all office locations for this firm with a National Database subscription.


  • Early
  • Growth
  • Seed



  • Communications & Networking
  • Food & Agriculture
  • Information Technology
  • Life Sciences & Healthcare



    Open Prairie Ventures is an early-stage venture capital firm investing in promising IT, wireless communication, and life science technology companies. Open Prairie Ventures was founded in 1999 as a venture capital firm focused on early-stage Midwest-based technolgy companies. The first investment fund, Open Prairie Ventures I, L.P. (OPV I), was formerly licensed by the Small Business Administration as a Small Business Investment Company (SBIC). In 2006, JIm Schultz, Michael Peck, and Dennis Beard recapitalized the SBA's Limited Partner interest in OPV I through a buyout of the SBA position. OPV I completed fifteen investments with four successful exits, including the 2007 IPO of TomoTherapy (NASDAQ: TOMO) and has four active portfolio investments remaining. The firm's second fund, Open Prairie Ventures II, provides early-stage venture capital to companies focused on the convergence of ag-tech and life science technologies. The fund deploys less than $15 million of syndicated capital to develop, commercialize, and exit.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Dennis Beard Chief Financial Officer & General Partner
    Jason Wrone Vice President of Investments
    Jim Schultz Founder & Managing Partner
    Michael Peck General Partner
    Pat Morand President


    Recent Funding Events (trailing 12 months):







      NewLeaf Symbiotics



      Series C







      NewLeaf Symbiotics



      Series C


    Portfolio companies include:

        web link

        web link

      Compact Particle Acceleration
        web link

        web link

        web link

        web link

        web link

      NewLeaf Symbiotics
        web link

      Novita Therapeutics
        web link

        web link


    Recent News: